Cargando…
Modulating the host immune response to fight against COVID-19: Where are we in 2021?
Autores principales: | Hertanto, Decsa Medika, Sutanto, Henry, Wiratama, Bayu Satria, Wungu, Citrawati Dyah Kencono |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8259726/ https://www.ncbi.nlm.nih.gov/pubmed/34224330 http://dx.doi.org/10.1080/21505594.2021.1943275 |
Ejemplares similares
-
Immunomodulation as a Potent COVID-19 Pharmacotherapy: Past, Present and Future
por: Hertanto, Decsa Medika, et al.
Publicado: (2021) -
Grapefruit Flavonoid Naringenin Sex-Dependently Modulates Action Potential in an In Silico Human Ventricular Cardiomyocyte Model
por: Sutanto, Henry, et al.
Publicado: (2022) -
Efficacy, safety, and immunogenicity of rurioctocog alfa pegol for prophylactic treatment in previously treated patients with severe hemophilia A: a systematic review and meta-analysis of clinical trials
por: Witarto, Bendix Samarta, et al.
Publicado: (2022) -
Case Report: Diabetic nephropathy aggravates the progression and prognosis of COVID-19-associated acute limb ischemia
por: Hertanto, Decsa Medika, et al.
Publicado: (2021) -
Reduction of Major Adverse Cardiovascular Events (MACE) after Bariatric Surgery in Patients with Obesity and Cardiovascular Diseases: A Systematic Review and Meta-Analysis
por: Sutanto, Andryanto, et al.
Publicado: (2021)